These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 5092121

  • 1. [Clinical experiences with a new beta 2-receptor stimulant in spastic lung diseases in pediatrics].
    Starnegg Q.
    Wien Med Wochenschr; 1971 May 29; 121(22):455-7. PubMed ID: 5092121
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical experiences with a new bronchospasmolytic agent in infancy and childhood].
    Nachtigall C.
    Med Monatsschr; 1968 Dec 29; 22(12):555-7. PubMed ID: 5709425
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of Tranquo-Alupent in asthmatic syndrome].
    Gentschy E, Ott N.
    Ther Ggw; 1969 Sep 29; 108(9):1298 passim. PubMed ID: 4910102
    [No Abstract] [Full Text] [Related]

  • 6. [On the treatment of spastic bronchitis in infants and children using a new bronchospasmolytic agent].
    Ertogan F, Stolting G, Russ D.
    Dtsch Med J; 1969 Jun 20; 20(12):413-5. PubMed ID: 5801770
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Salbutamol as a beta-adrenergic stimulator in bronchospastic pulmonary conditions].
    Dano P, Falholt W.
    Ugeskr Laeger; 1971 Apr 16; 133(15):685-8. PubMed ID: 4396922
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical experimentation using injectable metaproteronol].
    Pannain LS.
    Hospital (Rio J); 1967 Sep 16; 72(3):913-8. PubMed ID: 5304649
    [No Abstract] [Full Text] [Related]

  • 10. [Observations on the use of a sympathomimetic aerosol for diagnostic and therapeutic use].
    Gaffuri E, Reggiani A.
    Clin Ter; 1967 Dec 31; 43(6):559-65. PubMed ID: 5617981
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of spastic bronchitis with a new bronchospasmolytic agent].
    Heller K.
    Wien Med Wochenschr; 1972 Oct 14; 122(42):606-9. PubMed ID: 5081450
    [No Abstract] [Full Text] [Related]

  • 13. [Value of a new sympathomimetic in infantile respiratory diseases].
    Vialatte J.
    Sem Ther; 1966 Oct 14; 42(8):428-30. PubMed ID: 5994380
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of metaproterenol and isoproterenol aerosols: spirometric evaluation after two months' therapy.
    Chervinsky P, Belinkoff S.
    Ann Allergy; 1969 Dec 14; 27(12):611-6. PubMed ID: 5387334
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The influence of orciprenaline on circulation in the lung].
    Daum S, Stiksa J, Nikodýmová L, Petrle A, Svorcik C.
    Arzneimittelforschung; 1967 May 14; 17(5):565-8. PubMed ID: 5631585
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Bronchospasmolytic and extrabronchial action of Berotec (Fenoterol, Th 1165) in patients with asthma or chronic bronchitis with bronchial spasm].
    Rozniecki J, Grabski W.
    Pol Tyg Lek; 1975 Feb 17; 30(7):301-4. PubMed ID: 1118349
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.